Ben Stevens is an Editor at various publications, including Outsourced Pharma and Skiddle. He specializes in themes such as cannabis and psychedelics, with a focus on cannabidiol (CBD), cannabis business, and cannabis regulation, as well as competitive sports. Ben's work has been featured in a wide range of outlets, including Yahoo News UK, Bioprocess Online, and Edutopia.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Ben’s coverage mainly focuses on event coverage within the realm of sports, with particular emphasis on basketball and American football. Given this focus, he is likely to be most responsive to pitches that provide detailed previews or analyses of upcoming games or events in these sports.
For example, providing insights into key players' performances, injury updates, or emerging trends could be valuable for Ben's articles. Additionally, offering unique perspectives on coaching changes and their potential impact on teams might also garner his interest.
As there is no specific geographic focus mentioned for Ben's coverage area, pitches related to any NBA or NFL team matchup would be relevant regardless of location.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Sean Mclean, Ben Stevens
The UK's medical cannabis market has long been a locked box when it comes to reliable data. The fact that it is almost entirely private means that the data is largely proprietary, forcing us to piece together and model the market from snippets given to us by individual clinics or to
By: Ben Stevens, Sean Mclean
A Spanish startup has become one of only four companies authorised by Spain's medicines regulator to cultivate medical cannabis, positioning itself to supply export markets in the UK and Germany from a pharmaceutical-grade indoor facility in the Ribera region of Burgos.
By: Ben Stevens
Since April 2024, Berlin has cemented its place as the spiritual centre of the European cannabis industry. It is home not only to the policymakers, institutions, and business leaders that have shaped the
By: Rob Dale, Ben Stevens, Sarah Sinclair
Sanity Group has announced a new distribution partnership with Swiss cannabis operator Astrasana Holding AG , further expanding its footprint in the closely watched Swiss market.
By: Rob Dale, Ben Stevens
Vireo Growth (CSE: VREO) has agreed to acquire C21 Investments in an all-stock transaction that will extend its Nevada presence to 15 dispensaries and 158,000 square feet of cultivation and manufacturing capacity.
Trulieve's uplisting to the NYSE, the first of its kind in US history, has undoubtedly caught the attention of every large North American cannabis operator.
By: Ben Stevens
In the weeks since cannabis under a state medical licence was moved to Schedule III, US multi-state operators (MSOs) have wasted no time in capitalising on the historic reclassification.
By: Ben Stevens, Sarah Sinclair
By Curaleaf Laboratories , one of the UK's leading manufacturers and distributors of EU-GMP medical cannabis products and Herdade das
By: Ben Stevens, Scott Mazza
Thirteen years ago, Uruguay became the first country on the planet to officially legalise cannabis for recreational (adult-use) purposes. In December 2013, state-controlled cannabis retail sales, home cultivation, and social clubs were fully legalised by President José Mujica.
By: Ben Stevens, Scott Mazza
Curaleaf International has launched a free CPD-accredited online education platform for UK healthcare professionals to help close the training gap the country's professional medical community continues to face.
